HUM
33
2
DG
14
-3
CHRW
51
-6
WBA
64
4
AXP
69
2
XRAY
47
-2
MRK
33
3
EMR
64
-3
SLG
57
4
FSLR
63
5
TAP
60
2
TSN
28
-2
AAL
59
-4
FAST
46
-3
VMC
48
-2
MCHP
43
6
PRU
45
-2
EQR
40
-4
MCO
74
-3
APH
62
-3
HUM
33
2
DG
14
-3
CHRW
51
-6
WBA
64
4
AXP
69
2
XRAY
47
-2
MRK
33
3
EMR
64
-3
SLG
57
4
FSLR
63
5
TAP
60
2
TSN
28
-2
AAL
59
-4
FAST
46
-3
VMC
48
-2
MCHP
43
6
PRU
45
-2
EQR
40
-4
MCO
74
-3
APH
62
-3
Financhill
Back

Larimar Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
47

LRMR
Larimar Therapeutics

Last Price:
6.17
Seasonality Move:
30.38%
Sell
23

NBY
NovaBay Pharmaceuticals

Last Price:
0.58
Seasonality Move:
-6.51%
Sell
47
Larimar Therapeutics (LRMR) is a Sell

Is Larimar Therapeutics a Buy, Sell or Hold?

  • The current Larimar Therapeutics [LRMR] share price is $6.17. The Score for LRMR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • LRMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LRMR Stock Price Chart

What is Larimar Therapeutics's stock price today?

  • The Larimar Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

LRMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 42.32 Sell
Chaikin Money Flow: 34149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.78 - 7.72) Sell
Bollinger Bands (100): (6.49 - 8.27) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.63 Sell
Chaikin Money Flow: 40319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.57 - 0.71) Sell
Bollinger Bands (100): (0.4 - 0.86) Sell

LRMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.33 Sell
20-day SMA: 6.3 Sell
50-day SMA: 7.15 Sell
200-day SMA: 7.8 Sell
8-day EMA: 6.32 Sell
20-day EMA: 6.54 Sell
50-day EMA: 6.96 Sell
200-day EMA: 7.18 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Buy
20-day SMA: 0.62 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.61 Sell
50-day EMA: 0.67 Sell
200-day EMA: 4.92 Sell

Larimar Therapeutics Earnings Growth & LRMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.40 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Larimar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):